NewsRoom Articles - Page 208 of 599

TuesdayJan 18, 2022 4:20 am

420 with CNW — California Disburses $100M in Support of Cannabis Business Development

Last week, officials in California announced that the state had allocated $100 million in funding for the development of local cannabis markets, which would initially be used to help marijuana businesses become fully licensed. The California Department of Cannabis Control distributed the funds to 17 counties and cities where there are unequal numbers of provisional cannabis licenses. Some funding was also directed to areas with established social equity programs. This comes months after the department’s announcement that it was accepting applications for the local jurisdiction assistance grant program. The temporary licensing category was scheduled to expire on Jan. 1, 2022,…

FridayJan 14, 2022 4:20 pm

420 with CNW — CPG Trends That Marijuana Businesses Should Consider Implementing

Since the pandemic begun, there have been shifts in consumer purchasing habits with emerging technologies and packaging innovations such as digitization, remote analytics and AI leading to the development of a new level of company efficiencies. While not every packaging innovation can be applied to marijuana firms, some trends transforming the consumer packaged goods sector should be considered, including the following: AI and Digitization Digitization is helping improve product traceability and develop packaging automation efficiencies in the consumer packaged goods sector. The marijuana sector doesn’t have industry software solutions that allow them to collect, organize and analyze their packaging and…

FridayJan 14, 2022 9:00 am

After a Successful 2021, Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off 2022 With New Media Strategy, Plans for Clinical Study Advancements

Lexaria has multiple studies planned that will commence early in 2022 DehydraTECH increases Lexaria’s ability to leverage multiple markets, including the growing CBD sector, which is expected to meet and exceed $108 billion in revenue by 2027 DehydraTECH can increase the efficacy of the drugs being administered, offering faster absorption and lowering the delivery time In a strategic move to start off 2022, Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that it has signed an advertising and media contract with financial technology company SRAX (NASDAQ: SRAX). The contract will facilitate media buys and digital…

FridayJan 14, 2022 4:20 am

420 with CNW — New Study Finds Cannabis Breathalyzers Provide Inaccurate Results

New research has found that cannabis breathalyzers are inconsistent in measuring THC impairment. THC (tetrahydrocannabinol) is the primary psychoactive compound in marijuana that induces a high. This compound usually binds with receptors in the brain that control mood and pain, among other feelings. The study was carried out in Australia by University of Sydney researchers. For their research, the investigators conducted an analysis of 28 studies on the concentration of THC in saliva and blood and driving performance. The studies included in the analysis focused on how THC divided attention and impacted an individual’s reaction time. These two skills are…

ThursdayJan 13, 2022 4:20 pm

420 with CNW — Report Finds State-Legal Cannabis Markets Have Generated $10B in Taxes

Cannabis is without a doubt one of the fastest-growing industries in America. Despite being relatively young, America’s state-legal cannabis industry has been quite lucrative, generating billions of dollars in revenue and creating hundreds of thousands of new job opportunities. According to a newly released report on the industry, marijuana has been extremely kind to state coffers; since 2014, cannabis sales have provided states with legal marijuana markets more than $10 billion in tax revenue. The Marijuana Policy Project report states that since Colorado and Washington state sanctioned recreational cannabis sales in 2012, a wave of cannabis reform has swept across…

ThursdayJan 13, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Targeting Increased Revenue and Margins with Strategic Focus on Vertical Integration

RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOY The company is pursuing vertical integration in multiple states, including Florida, California, and Michigan In Florida, RWB has launched cultivation operations and a processing facility expected to provide additional inventory for its Springhill dispensary, as well as three new dispensaries set to be opened in Q1 2022 According to RWB Chairman and CEO Brad Rogers, vertical integration will help drive increased revenue and margins for the company In the third quarter of fiscal 2021, multistate cannabis operator and house of premium brands Red White & Bloom…

ThursdayJan 13, 2022 4:20 am

420 with CNW — Illinois Breaks Yet Another Cannabis Sales Record in December

All things considered, 2021 was a pretty good year for cannabis. Unlike most sectors, the state-legal cannabis industry didn’t take much of a beating from the coronavirus pandemic, and when 2021 came to a close, cannabis businesses across the country were doing relatively well. So while businesses in other industries were struggling to recover from the crippling effects of the pandemic, marijuana sellers were making bank. For Illinois, 2021 was probably the best year the state’s cannabis industry had ever seen. Cannabis sellers in Illinois sold cannabis worth a whopping $137.9 million in December 2021, breaking yet another monthly sales…

WednesdayJan 12, 2022 4:20 pm

420 with CNW — Two DEA-Approved Firms Harvest Cannabis Crop, Ending MU Cultivation Monopoly

After more than five decades of being in place, the federal monopoly on marijuana manufacturing ended earlier last week. Before its cessation, only the University of Mississippi was allowed by the Drug Enforcement Administration (“DEA”) to grow cannabis for study purposes. The DEA had in the recent past announced that it would take action to end the monopoly and permit additional manufacturers. In May of last year, a number of companies received conditional approvals for their applications. Two of them — the Biopharmaceutical Research Company (“BRC”) and Groff North America Hemplex — revealed that they had recently received official registration…

WednesdayJan 12, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Distribution Deal Increases CBD Product Reach to Mexico, Latin America

Plant-based wellness and lifestyle brand cultivator Flora Growth Corp. is building on its initial revenues from 2021 with distribution expansion into Mexico The company will initially distribute a portfolio of 12 Mind Naturals skincare products through e-commerce but intends to eventually locate its products in brick-and-mortar stores The company’s deal with Mexican department store Coppel gives it a reach nationwide through its online marketplace and, perhaps eventually, Coppel’s 1,253 stores Flora Growth’s products will also be distributed through global retail giant Walmart’s e-commerce platform — one of the leading retail chains in Central America The company also has an outdoor…

WednesdayJan 12, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates Productive Year for Blood Pressure Drug Solution with Eye on Advancing Clinical Studies in 2022

Lexaria Bioscience’s ongoing human clinical studies for its patented and trademarked DehydraTECH technology have yielded progressively optimistic results in 2021 regarding DehydraTECH’s ability to provide effective solutions for the cardiovascular industry DehydraTECH is being studied for its capacity to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation DehydraTECH-CBD underwent three human clinical studies in 2021 that examined its ability to reduce arterial stiffness and blood pressure without creating unintended negative consequences A fourth, more comprehensive study was approved at year’s end, as the next step…

News and publishing service for cannabis related companies

Contact us: 512.354.7000